These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 7034934

  • 1. Clinical and pharmacologic evaluation of split-dose intermittent therapy with dianhydrogalactitol.
    Eagan RT, Ames MM, Powis G, Kovach JS.
    Cancer Treat Rep; 1982 Feb; 66(2):283-7. PubMed ID: 7034934
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Phase II study of the combination of dianhydrogalactitol, doxorubicin, and cisplatin (DAP) in patients with advanced squamous cell lung cancer.
    Eagan RT, Frytak S, Nichols WC, Ingle JN, Creagan ET, Kvols LK.
    Cancer Treat Rep; 1981 Feb; 65(5-6):517-9. PubMed ID: 7195306
    [No Abstract] [Full Text] [Related]

  • 4. Phase I trial of dianhydrogalactitol administered Iv in a weekly schedule.
    Vogel CL, Winton EF, Moore MR, Sohner S.
    Cancer Treat Rep; 1976 Jul; 60(7):895-901. PubMed ID: 795538
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A safety and pharmacokinetic study of a mixed-backbone oligonucleotide (GEM231) targeting the type I protein kinase A by two-hour infusions in patients with refractory solid tumors.
    Chen HX, Marshall JL, Ness E, Martin RR, Dvorchik B, Rizvi N, Marquis J, McKinlay M, Dahut W, Hawkins MJ.
    Clin Cancer Res; 2000 Apr; 6(4):1259-66. PubMed ID: 10778949
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Phase I trial of the cryptophycin analogue LY355703 administered as an intravenous infusion on a day 1 and 8 schedule every 21 days.
    Stevenson JP, Sun W, Gallagher M, Johnson R, Vaughn D, Schuchter L, Algazy K, Hahn S, Enas N, Ellis D, Thornton D, O'Dwyer PJ.
    Clin Cancer Res; 2002 Aug; 8(8):2524-9. PubMed ID: 12171879
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Phase I and pharmacokinetic study of triapine, a potent ribonucleotide reductase inhibitor, administered daily for five days in patients with advanced solid tumors.
    Murren J, Modiano M, Clairmont C, Lambert P, Savaraj N, Doyle T, Sznol M.
    Clin Cancer Res; 2003 Sep 15; 9(11):4092-100. PubMed ID: 14519631
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Phase I and pharmacokinetic studies of DON.
    Kovach JS, Eagan RT, Powis G, Rubin J, Creagan ET, Moertel CG.
    Cancer Treat Rep; 1981 Sep 15; 65(11-12):1031-6. PubMed ID: 7296548
    [Abstract] [Full Text] [Related]

  • 16. Preliminary study of the combination, dianhydrogalactitol, cis-diaminedichloroplatinum (II), and VP-16-213 in patients with advanced cancer.
    Creagan ET, Eagan RT, Kvols LK.
    Oncology; 1981 Sep 15; 38(5):260-1. PubMed ID: 7196561
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [The clinical phase I study of TNP-351. The TNP-351 Research Committee].
    Taguchi T, Niitani H, Furue H, Tsukagoshi S, Kanamaru R, Hasegawa K, Akazawa S, Yoneda S, Tominaga T, Sasaki T.
    Gan To Kagaku Ryoho; 1995 Feb 15; 22(2):259-71. PubMed ID: 7857102
    [Abstract] [Full Text] [Related]

  • 20. Phase I and pharmacological study of the pulmonary cytotoxin 4-ipomeanol on a single dose schedule in lung cancer patients: hepatotoxicity is dose limiting in humans.
    Rowinsky EK, Noe DA, Ettinger DS, Christian MC, Lubejko BG, Fishman EK, Sartorius SE, Boyd MR, Donehower RC.
    Cancer Res; 1993 Apr 15; 53(8):1794-801. PubMed ID: 8467498
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.